GENBIO

GenBio Inc is an early-stage biotechnology company that researches novel therapeutics from a variety of extracts. GenBio has, based on recent USA research, created an Investigational New Drug (IND) research program from novel natural compounds that are highly effective as anti-inflammatory agents... SARS-CoV-19: GenBio Inc is fast tracking its proprietary NME and NCE that inhibits both the pathogens P. aeruginosa and Klebsiella pneumoniae - known bacteria associated with secondary infections that can cause significant lung infections and damage. The goal is to inhibit pathogens in the throat prior to spreading to the lungs. Our program will possibly be fast tracked under the ‘CTAP' FDA program. Research in this area is critical and as a key support during future pandemics... GenBio, Inc. is a Biotechnology Company specializing in researching a rare natural extract with significant phyto-activity profiles.

Also known as: GenBio Inc